Presentation of Inflammatory Arthritis
Inflammatory arthritis typically presents with symmetric polyarthritis affecting small joints of the hands and feet, accompanied by prolonged morning stiffness lasting more than 1 hour, and joint swelling that improves with movement rather than rest. 1
Key Clinical Features
Joint Involvement Pattern
- Small joints predominantly affected: metacarpophalangeal, proximal interphalangeal, wrist, and metatarsophalangeal joints 1, 2
- Symmetric distribution is characteristic, though asymmetric patterns can occur 1
- Any appendicular joint may be involved, including knees, ankles, elbows, and shoulders 1
- Distal interphalangeal joints are typically spared in rheumatoid arthritis 2
Cardinal Symptoms
- Morning stiffness: Duration of ≥1 hour before maximal improvement is the hallmark feature 1, 3
- Joint swelling: Tender, boggy synovitis on palpation 1, 2
- Pain pattern: Symptoms that respond to NSAIDs or corticosteroids but not to opioids suggest inflammatory arthritis 4, 5
Timing and Onset Patterns
The presentation varies considerably:
- Insidious onset (most common): Gradual development of symmetric small joint pain and swelling 2
- Acute/subacute onset (25% of cases): Rapid symptom development 2
- Palindromic pattern: Recurrent episodes of oligoarthritis without residual damage 2
- Monoarticular presentation: Single joint involvement, either slow or acute 2
Critical Diagnostic Features
History Elements to Elicit
- Age and gender: Typical onset around 55 years; women affected 2:1 compared to men 1
- Duration of symptoms: ≥6 weeks increases likelihood of persistent disease 3
- Functional impairment: Early loss of ability to perform daily activities 1, 3
- Number of joints involved: ≥3 joints predicts persistence 3
- Pattern of involvement: Small joints, knees, or symmetric distribution 3
Physical Examination Findings
- Joint swelling with tenderness on palpation 1
- Reduced range of motion in affected joints 4
- Warmth over involved joints (though less pronounced than in septic arthritis)
- Axial/entheseal involvement: Check for spinal or tendon insertion point tenderness 3
Extra-Articular Manifestations (Markers of Severe Disease)
- Subcutaneous nodules 1
- Interstitial lung disease 1
- Vasculitis 1
- Inflammatory eye disease (scleritis, uveitis) 1
- Constitutional symptoms: Fatigue, fever, weight loss, malaise 2
Common Pitfalls to Avoid
Do Not Confuse With:
- Osteoarthritis: Pain worsens with activity, minimal morning stiffness (<30 minutes), bony rather than soft tissue swelling
- Fibromyalgia: Widespread pain without objective joint swelling or elevated inflammatory markers
- Soft tissue rheumatism: Tendinitis or bursitis without true synovitis
- Crystal arthropathy: Often monoarticular, acute onset, may have tophi
- Septic arthritis: Monoarticular, acute, with systemic toxicity
Critical Distinction
The key differentiating feature is prolonged morning stiffness (>1 hour) that improves with movement, combined with objective joint swelling on examination. 5, 6 Inflammatory markers (ESR, CRP) are typically elevated, but their absence does not exclude inflammatory arthritis 3.
Prognostic Indicators
Predictors of Persistent/Severe Disease
- Disease duration ≥6 weeks 3
- Morning stiffness >30 minutes 3
- Involvement of ≥3 joints 3
- Small joint or knee involvement 3
- Positive rheumatoid factor or anti-CCP antibodies 3
- Presence of radiographic erosions 3
- Extra-articular manifestations 1
Impact on Morbidity and Mortality
Untreated inflammatory arthritis leads to significant disability and shortened life expectancy. 1 More than one-third of patients develop work disability, with 80% working at 2 years declining to 68% at 5 years 1. Life expectancy is reduced by 3-5 years, particularly in those with extra-articular disease 1. Cardiovascular disease represents the leading cause of death, with risk comparable to diabetes mellitus 7.
When to Refer Urgently
Immediate rheumatology referral is warranted when:
- Confirmed synovitis (joint swelling) is present 8
- Symptoms persist >6 weeks 3
- Multiple joints involved (≥3) 3
- Positive autoantibodies (RF, anti-CCP) 3
- Functional impairment present 3
Early referral and aggressive treatment within the "window of opportunity" significantly improves long-term outcomes, reduces disability, and may prevent irreversible joint damage 1, 8.